M2D2 IMPACT Accelerator
A 12-week accelerator program that aims to advance early-stage companies looking to reshape the future of innovation.
Cycle 7 has officially ended. Learn more about all of our great start-ups by clicking the button below.
What is IMPACT?
- A 12-week cohort-based accelerator program to help connect startups to the expertise and resources needed to advance their technologies
- Companies selected through a competitive application process; review criteria: in scope, deemed by experts to be most promising and having the highest likelihood of success
- Mentors matched 1:1 to participants to share commercialization insights & guidance
- 11 weeks of virtual sessions followed by an end-of-program pitch & networking event
For Cycle 7 of IMPACT, Diversity, Equity, and Inclusion is of utmost importance and is reflected throughout the application and review processes, and further, throughout the curriculum.
M2D2 is collaborating with FORGE to support two unique innovation tracks:
- Minimally and non-invasive medical devices that advance the standard of care and/or make procedures more accessible (no SaaMD unless has a novel physical component as part of the solution).
- Surgical
- Image guidance
- Minimally invasive surgical instruments/technologies to ensure better outcomes and shorter recovery times
- Non-surgical
- Brain sensor
- Non-invasive neural interfaces
- Structural materials
- Functional materials
- Biomaterials
- Others.
- Surgical
IMPACT Pitch-Off Cycle 4 Highlights
How our past members feel about the IMPACT program.
-
The content of the live events was excellent, and the support and encouragement offered by M2D2’s leadership team was exceptional."
Laura Owen, CEO & Founder of HealthyID -
We were thrilled to be accepted into the program, and our expectations were only exceeded."
Ben Merewitz, CEO & Co-founder of Agile Devices -
We would recommend the IMPACT program to any startup willing to learn and advance their company to the next level.”
Bryan Nolan, CEO & Founder of myBiometr
-
The IMPACT team assisted with key introductions to investors and strategic partners."
Gitte Pederson, CEO & Co-founder of Genomic Expression
-
The accelerator had a positive impact on Avisi and we highly recommend it to other startups like us.”
Rui Jing Jiang, CEO & Co-founder of Avisi
-
I cannot recommend M2D2 IMPACT enough.”
Casey Grage, CEO & Founder of Hubly Surgical
In their own words...
Learn about the IMPACT experience first-hand from alumni Hubly Surgical and their CEO Casey Grage.